^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    folate-tubulysin (EC1456)

    i
    Other names: EC1456, EC 1456, EC-1456
    Associations

    News

    Trials
    Company:
    Novartis
    Drug class:
    Microtubule inhibitor, Folate receptor 1 inhibitor
    Related drugs:
    Associations

    News

    Trials
    over6years
    Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, Recruiting, Endocyte
    Clinical • New P1 trial
    |
    EGFR (Epidermal growth factor receptor) • PD-L1 (Programmed death ligand 1) • ALK (Anaplastic lymphoma kinase) • BRCA1 (Breast cancer 1, early onset) • BRCA2 (Breast cancer 2, early onset) • ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS) • BRCA (Breast cancer early onset)
    |
    BRCA mutation
    |
    folate-tubulysin (EC1456)